Literature DB >> 28165854

Treatment optimization in multiple sclerosis: how do we apply emerging evidence?

Tjalf Ziemssen1, Katja Thomas1.   

Abstract

Entities:  

Keywords:  Treatment optimization; high efficacy treatment; multiple sclerosis; no evidence of disease activity; treatment switch

Mesh：

Substances：

Year:  2017        PMID： 28165854     DOI： 10.1080/1744666X.2017.1292135

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN： 1744-666X            Impact factor:   4.473


× No keyword cloud information.
  6 in total

1.  Profiling individual clinical responses by high-frequency serum neurofilament assessment in MS.

Authors:  Katja Akgün; Nicole Kretschmann; Rocco Haase; Undine Proschmann; Hagen H Kitzler; Heinz Reichmann; Tjalf Ziemssen
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-04-08

2.  Exploring polypharmacy phenomenon in newly diagnosed relapsing-remitting multiple sclerosis: a cohort ambispective single-centre study.

Authors:  Aurora Zanghì; Emanuele D'Amico; Salvatore Lo Fermo; Francesco Patti
Journal:  Ther Adv Chronic Dis       Date:  2021-02-27       Impact factor: 5.091

3.  Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world.

Authors:  Tjalf Ziemssen; Katja Thomas
Journal:  Ther Adv Neurol Disord       Date:  2017-08-04       Impact factor: 6.570

4.  Patient satisfaction and healthcare services in specialized multiple sclerosis centres in Germany.

Authors:  Veit Becker; Volker Heeschen; Katrin Schuh; Heinke Schieb; Tjalf Ziemssen
Journal:  Ther Adv Neurol Disord       Date:  2018-01-23       Impact factor: 6.570

5.  The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis.

Authors:  T Derfuss; J Sastre-Garriga; X Montalban; M Rodegher; J Wuerfel; L Gaetano; D Tomic; A Azmon; C Wolf; L Kappos
Journal:  Mult Scler J Exp Transl Clin       Date:  2020-03-30

6.  The Dresden Protocol for Multidimensional Walking Assessment (DMWA) in Clinical Practice.

Authors:  Katrin Trentzsch; Marie Luise Weidemann; Charlotte Torp; Hernan Inojosa; Maria Scholz; Rocco Haase; Dirk Schriefer; Katja Akgün; Tjalf Ziemssen
Journal:  Front Neurosci       Date:  2020-10-26       Impact factor: 4.677
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.